Literature DB >> 12078969

Benign mucinous cystadenoma with stromal luteinization during pregnancy: a hormonally responsive tumor and a rare cause of fetal intrauterine growth restriction.

Hussein S Qublan1, Ahmad S Al-Ghoweri, Nabih S Al-Kaisi, Sami A Abu-Khait.   

Abstract

A 32-year-old woman, gravida 4, para 3, had a benign right ovarian mucinous cystadenoma. It was diagnosed 1 month before conception, measured 9 x 7cm, and reached 33 x 24 x 20cm at 38 weeks gestation. Cesarean delivery of a 2250 g normal female infant took place, and the removal of a 6300 g right ovarian cystic mass was also performed. Microscopic and immunohistochemical studies of the cyst wall revealed stromal luteinization and a strong reaction with antiserum to testosterone, estrogen and progesterone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12078969     DOI: 10.1046/j.1341-8076.2002.00020.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Diagnosis and management of a giant ovarian cyst in the gravid-puerperium period: a case report.

Authors:  Sibraogo Kiemtoré; Hyacinthe Zamané; Yobi Alexis Sawadogo; Rodrigue Sansan Sib; Evelyne Komboigo; Ali Ouédraogo; Blandine Bonané
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-26       Impact factor: 3.007

2.  Successful Vaginal Delivery despite a Huge Ovarian Mucinous Cystadenoma Complicating Pregnancy: A Case Report.

Authors:  Dipak Mandi; Ratan Chandra Mondal; Debasish Bhar; Ashok Kumar Maity; Malay Kr Nandi; Kinkar Singh
Journal:  Iran J Med Sci       Date:  2013-12

3.  A huge ovarian mucinous cystadenoma causing virilization, preterm labor, and persistent supine hypotensive syndrome during pregnancy.

Authors:  Suna Kabil Kucur; Canan Acar; Osman Temizkan; Aysim Ozagari; Ilay Gozukara; Atif Akyol
Journal:  Autops Case Rep       Date:  2016-06-30

4.  Giant Ovarian Mucinous Cystadenoma Complicating Term Pregnancy.

Authors:  Sangeeta Mishra; Manoj Yadav; Sripad J Walawakar
Journal:  JNMA J Nepal Med Assoc       Date:  2018 Mar-Apr       Impact factor: 0.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.